PBM: Psyence Biomedical Limited Price Target Chart

Psyence Biomedical Ltd. (PBM) specializes in the exploration of copper deposits in Canada, where resource volume determines its market value. Current price action reflects the 0.00 indicator. Simultaneously, the business is developing unique psychedelic treatments to alleviate the suffering of cancer patients. Management is currently restructuring internal processes following the consolidation of assets, striving to maintain shareholder confidence through strict adherence to medical trial timelines.

PBM Psyence Bio: Price Target Chart in the range 02/21/2024 - 11/11/2026

Analytical breakdowns for Psyence Biomedical Limited (PBM)

- share price and expert price forecast:

Quote Chart pacificbayminerals.com|PBM - Analyst Consensus Forecast

- market capitalization information:

Market Value Psyence Biomedical Limited|PBM - Total Company Value

- issuer book value statistics:

Accounting Value per Share Psyence Biomedical|PBM - Company Book Value|Market Capitalization to Net Assets pacificbayminerals.com|PBM - Company Total Assets

- issuer credit burden and liquidity indicators:

- business earnings and investment ratios data:

PBM - Net Income|Expected Net Income Psyence Biomedical Ltd.|PBM - Price to Earnings Ratio|Price to Expected Earnings Ratio Psyence Biomedical Ltd|PBM - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Psyence Biomedical Limited|PBM - Operating profit before deduction of amortization|Net earnings per one share for the last twelve months Psyence Biomedical|PBM - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months pacificbayminerals.com|PBM - Earnings growth in current year|Expected earnings per share trend next year Psyence Biomedical Ltd.

Fundamental company analysis:pacificbayminerals.com, PBM

Finished products of Psyence Biomedical Limited

The consensus forecast aggregates average target share prices from various investment houses, reflecting the balance between objective calculations and market expectations during periods of multiplier revisions. An analysis of the current consensus target price for Psyence Biomedical Ltd. (PBM) confirms the business's resilience, as reliable logistics in the development of Canadian deposits minimize operational risks, providing fundamental support for the market valuation.

Competitors of Psyence Biomedical Ltd.